Wiskott-Aldrich syndrome and molluscum contagiosum: a therapeutic challenge after reaction to cidofovir.
Hicks
Lindsey D
LD
Department of Dermatology, University of Texas-Houston Health Science Center, Houston, Texas, USA. Lindsey.d.hicks@uth.tmc.edu
Duvic
Madeleine
M
D017255:Acitretin / Q000008:administration & dosage; D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000284:Administration, Oral; D000287:Administration, Topical; D000328:Adult; D000634:Aminoquinolines / Q000008:administration & dosage; D000998:Antiviral Agents / Q000008:administration & dosage*; D000077404:Cidofovir; D003596:Cytosine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004351:Drug Resistance; D006801:Humans; D000077271:Imiquimod; D016867:Immunocompromised Host; D016403:Lymphoma, Large B-Cell, Diffuse / Q000150:complications / Q000188:drug therapy; D008297:Male; D008976:Molluscum Contagiosum / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D063065:Organophosphonates / Q000008:administration & dosage*; D014923:Wiskott-Aldrich Syndrome / Q000150:complications* / Q000276:immunology
D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D000998:Antiviral Agents; D063065:Organophosphonates; D003596:Cytosine; D000077404:Cidofovir; D017255:Acitretin; D000077271:Imiquimod